Patient Perspectives on Prostate MRI during Active Surveillance for Prostate Cancer

What is it about?

This study conducted a qualitative analysis of patient experiences with prostate magnetic resonance imaging (MRI) and MRI-ultrasound fusion biopsy during active surveillance for low- and intermediate-risk prostate cancer. The study found that patients valued prostate MRI as a tool that enhances their confidence in the initial diagnosis and monitoring of prostate cancer. Some patients expressed a preference for greater information about their prostate MRI findings and their clinical implications. The study identified that the perception that higher quality imaging provides more accurate assessments of disease status can increase confidence in selecting active surveillance. Some participants were reassured by the perception that they were receiving state-of-the-art imaging evaluations. However, until more rigorous evidence is available, patients emphasized the need for information sources to tailor levels of detail to patient preferences and comfort level. The study also found that patients identified new and evolving healthcare system-level challenges when receiving imaging reports, such as anxiety caused by the delivery of imaging results via electronic health record portals. The study suggested that healthcare systems should consider providing clear timelines when results will be discussed and increasing telehealth access for more timely counselling.

Featured Image

Why is it important?

This research is important because it provides insights into patient perspectives on the role of prostate MRI during active surveillance for prostate cancer and its impact on decision-making. Understanding patient experiences and preferences regarding prostate MRI can help healthcare providers to better align practice with patient needs and improve patient experience, education, and counseling during active surveillance. Key Takeaways: 1. Patients value prostate MRI as a tool that enhances their confidence in the initial diagnosis and monitoring of prostate cancer. 2. Some patients expressed a preference for greater information about their prostate MRI findings and their clinical implications. 3. The perception that higher quality imaging provides more accurate assessments of disease status can increase confidence in selecting active surveillance. 4. Patients identified new and evolving healthcare system-level challenges when receiving imaging reports, such as anxiety and decisional uncertainty. 5. Healthcare systems should consider providing clear timelines when results will be discussed, increasing telehealth access for more timely counseling, and integrating simple, plain language summaries of actionable clinical findings and timelines for next steps.